Literature DB >> 21594753

The evolving classification of dementia: placing the DSM-V in a meaningful historical and cultural context and pondering the future of "Alzheimer's".

Daniel R George1, Peter J Whitehouse, Jesse Ballenger.   

Abstract

Alzheimer's disease is a 100-year-old concept. As a diagnostic label, it has evolved over the 20th and 21st centuries from a rare diagnosis in younger patients to a worldwide epidemic common in the elderly, said to affect over 35 million people worldwide. In this opinion piece, we use a constructivist approach to review the early history of the terms "Alzheimer's disease" and related concepts such as dementia, as well as the more recent nosological changes that have occurred in the four major editions of the Diagnostic and Statistical Manual since 1952. A critical engagement of the history of Alzheimer's disease and dementia, specifically the evolution of those concepts in the DSM over the past 100 years, raises a number of questions about how those labels and emergent diagnoses, such as Neurocognitive Disorders and Mild Cognitive Impairment, might continue to evolve in the DSM-V, due for release in 2013.

Entities:  

Mesh:

Year:  2011        PMID: 21594753     DOI: 10.1007/s11013-011-9219-x

Source DB:  PubMed          Journal:  Cult Med Psychiatry        ISSN: 0165-005X


  51 in total

Review 1.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

2.  Cross-national comparability of burden of disease estimates: the European Disability Weights Project.

Authors:  Marie-Louise Essink-Bot; Joaquin Pereira; Claire Packer; Michael Schwarzinger; Kristina Burstrom
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

Review 3.  Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life.

Authors:  Brenda L Plassman; John W Williams; James R Burke; Tracey Holsinger; Sophiya Benjamin
Journal:  Ann Intern Med       Date:  2010-06-14       Impact factor: 25.391

Review 4.  Clinical trials in mild cognitive impairment: lessons for the future.

Authors:  V Jelic; M Kivipelto; B Winblad
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

5.  Banking on stories for healthier cognitive ageing.

Authors:  Peter J Whitehouse; Daniel George
Journal:  Lancet       Date:  2009-04-04       Impact factor: 79.321

Review 6.  The concept of dementia: retain, reframe, rename or replace?

Authors:  Alexander F Kurz; Nicola T Lautenschlager
Journal:  Int Psychogeriatr       Date:  2009-10-09       Impact factor: 3.878

7.  Vector diagnostics in dementia derived from Bayes' theorem.

Authors:  A B Mitnitski; J E Graham; A J Mogilner; K Rockwood
Journal:  Am J Epidemiol       Date:  1997-10-15       Impact factor: 4.897

Review 8.  Mild cognitive impairment: new neuropsychological and pharmacological target.

Authors:  Rafael A Rivas-Vazquez; Cecilia Mendez; Gustavo J Rey; Enrique J Carrazana
Journal:  Arch Clin Neuropsychol       Date:  2004-01       Impact factor: 2.813

9.  The neuropathology of older persons with and without dementia from community versus clinic cohorts.

Authors:  Julie A Schneider; Neelum T Aggarwal; Lisa Barnes; Patricia Boyle; David A Bennett
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 10.  Bringing the social back in: a critique of the biomedicalization of dementia.

Authors:  K A Lyman
Journal:  Gerontologist       Date:  1989-10
View more
  7 in total

Review 1.  The end of Alzheimer's disease--from biochemical pharmacology to ecopsychosociology: a personal perspective.

Authors:  Peter J Whitehouse
Journal:  Biochem Pharmacol       Date:  2013-12-01       Impact factor: 5.858

Review 2.  Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.

Authors:  Paul J Derry; Muralidhar L Hegde; George R Jackson; Rakez Kayed; James M Tour; Ah-Lim Tsai; Thomas A Kent
Journal:  Prog Neurobiol       Date:  2019-10-08       Impact factor: 11.685

3.  Learning From the Cultural Challenge of Dementia.

Authors:  Michael Chapman; Jennifer Philip; Paul Komesaroff
Journal:  J Bioeth Inq       Date:  2019-06-04       Impact factor: 1.352

4.  Cultural representations of dementia.

Authors:  Alexandra Hillman; Joanna Latimer
Journal:  PLoS Med       Date:  2017-03-28       Impact factor: 11.069

5.  Ethical issues in early diagnosis and prevention of Alzheimer disease.

Authors:  Peter J Whitehouse
Journal:  Dialogues Clin Neurosci       Date:  2019-03       Impact factor: 5.986

6.  Somaticization, the making and unmaking of minded persons and the fabrication of dementia.

Authors:  Alexandra Hillman; Joanna Latimer
Journal:  Soc Stud Sci       Date:  2019-03-05       Impact factor: 3.885

7.  A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II.

Authors:  Fiona E Matthews; Antony Arthur; Linda E Barnes; John Bond; Carol Jagger; Louise Robinson; Carol Brayne
Journal:  Lancet       Date:  2013-07-17       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.